Literature DB >> 35836384

COVID-19 vaccination coverage, vaccine hesitancy and opioid use disorder: Correspondence.

Rujittika Mungmunpuntipantip1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Year:  2022        PMID: 35836384      PMCID: PMC9349915          DOI: 10.1111/dar.13514

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


× No keyword cloud information.
Dear Editor, We would like to share some ideas on the publication ‘COVID‐19 vaccination coverage and vaccine hesitancy among people with opioid use disorder in Barcelona, Spain’ [1]. More than two‐thirds of the sample of persons with opioid use disorder were fully vaccinated, according to Vallecillo et al., but among people with opioid use disorder on opioid agonist therapy who were referred to vaccination clinic sites, complacency and convenience were significant barriers to completing vaccination [1]. Acceptance of COVID‐19 immunisation is regulated by several factors, and the pattern may vary according to the environment and outbreak level. Furthermore, as data on vaccine efficacy and safety change, adoption trends may shift dramatically [2]. And indeed, according to a recent study, acceptance patterns are shifting over time [3]. To examine the impact of vaccination willingness and associated factors, a longitudinal study rather than a cross‐sectional analysis might be useful.

CONFLICT OF INTEREST

The authors declare no conflict of interest.
  3 in total

1.  Temporal changes in factors associated with COVID-19 vaccine hesitancy and uptake among adults in Hong Kong: Serial cross-sectional surveys.

Authors:  Jingyi Xiao; Justin K Cheung; Peng Wu; Michael Y Ni; Benjamin J Cowling; Qiuyan Liao
Journal:  Lancet Reg Health West Pac       Date:  2022-03-29

2.  COVID-19 vaccination coverage and vaccine hesitancy among people with opioid use disorder in Barcelona, Spain.

Authors:  Gabriel Vallecillo; Xavier Durán; Irene Canosa; Albert Roquer; Maria C Martinez; Rafael Perelló
Journal:  Drug Alcohol Rev       Date:  2022-06-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.